Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

IP LitigationLife Sciences

Law360: Justices Struggle With BPCIA Enigma

April 28, 2017

IP LitigationLife Sciences

Law360: Justices Struggle With BPCIA Enigma

April 28, 2017

Back to Fish's Litigation Blog

 

In a recent article for Law360, Fish attorneys Tasha Francis and Jenny Shmuel discuss recent oral arguments for the Amgen Inc. v. Sandoz Inc. case, in which the U.S. Supreme Court has its first chance to weigh in on the Biologics Price Competition and Innovation Act (BPCIA).

To read the full article, visit Law360.

Related Tags

BPCIA
Amgen
Sandoz
Amgen v. Sandoz

Blog Authors

Headshot
Jenny Shmuel, Ph.D. | Associate

Jenny Shmuel is an Associate in the Boston office of Fish & Richardson. Dr. Shmuel has represented clients on a range of intellectual property matters, with an emphasis on medical device and pharmaceutical technologies. Since joining the firm, Dr. Shmuel has worked to build...

Headshot
Tasha M. Francis, Ph.D. | Associate

Tasha Francis, Ph.D., an associate in Fish & Richardson’s Twin Cities office, practices intellectual property litigation with an emphasis on patent litigation. Dr. Francis has represented plaintiffs and defendants in cases involving medical devices, biotechnology and...

Leave a Reply

Your email address will not be published. Required fields are marked *